AMDOCS LTD Quarterly Revenues in USD from Q4 2013 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Amdocs Ltd quarterly/annual Revenues history and growth rate from Q4 2013 to Q3 2023.
  • Amdocs Ltd Revenues for the quarter ending September 30, 2023 was $1.24B, a 6.52% increase year-over-year.
  • Amdocs Ltd Revenues for the twelve months ending September 30, 2023 was $4.89B, a 6.79% increase year-over-year.
  • Amdocs Ltd annual Revenues for 2023 was $4.89B, a 6.79% increase from 2022.
  • Amdocs Ltd annual Revenues for 2022 was $4.58B, a 6.72% increase from 2021.
  • Amdocs Ltd annual Revenues for 2021 was $4.29B, a 2.87% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $4.89B $1.24B +$76.1M +6.52% Jul 1, 2023 Sep 30, 2023 20-F 2023-12-13
Q2 2023 $4.81B $1.24B +$75.7M +6.52% Apr 1, 2023 Jun 30, 2023 20-F 2023-12-13
Q1 2023 $4.74B $1.22B +$78M +6.81% Jan 1, 2023 Mar 31, 2023 20-F 2023-12-13
Q4 2022 $4.66B $1.19B +$81.1M +7.34% Oct 1, 2022 Dec 31, 2022 20-F 2023-12-13
Q3 2022 $4.58B $1.17B +$79.2M +7.28% Jul 1, 2022 Sep 30, 2022 20-F 2023-12-13
Q2 2022 $4.5B $1.16B +$94M +8.82% Apr 1, 2022 Jun 30, 2022 20-F 2023-12-13
Q1 2022 $4.4B $1.15B +$96.5M +9.21% Jan 1, 2022 Mar 31, 2022 20-F 2023-12-13
Q4 2021 $4.31B $1.1B +$18.3M +1.68% Oct 1, 2021 Dec 31, 2021 20-F 2023-12-13
Q3 2021 $4.29B $1.09B +$34.4M +3.26% Jul 1, 2021 Sep 30, 2021 20-F 2022-12-13
Q2 2021 $4.25B $1.07B +$40.1M +3.9% Apr 1, 2021 Jun 30, 2021 20-F 2022-12-13
Q1 2021 $4.21B $1.05B +$801K +0.08% Jan 1, 2021 Mar 31, 2021 20-F 2022-12-13
Q4 2020 $4.21B $1.09B +$44.4M +4.26% Oct 1, 2020 Dec 31, 2020 20-F 2022-12-13
Q3 2020 $4.17B $1.05B +$22.7M +2.2% Jul 1, 2020 Sep 30, 2020 20-F 2021-12-09
Q2 2020 $4.15B $1.03B +$1.5M +0.15% Apr 1, 2020 Jun 30, 2020 20-F 2021-12-09
Q1 2020 $4.14B $1.05B +$28.3M +2.77% Jan 1, 2020 Mar 31, 2020 20-F 2021-12-09
Q4 2019 $4.12B $1.04B +$29.9M +2.96% Oct 1, 2019 Dec 31, 2019 20-F 2021-12-09
Q3 2019 $4.09B $1.03B +$27.7M +2.76% Jul 1, 2019 Sep 30, 2019 20-F 2020-12-14
Q2 2019 $4.06B $1.02B +$22.5M +2.25% Apr 1, 2019 Jun 30, 2019 20-F 2020-12-14
Q1 2019 $4.04B $1.02B +$27.3M +2.75% Jan 1, 2019 Mar 31, 2019 20-F 2020-12-14
Q4 2018 $4.01B $1.01B +$34.3M +3.51% Oct 1, 2018 Dec 31, 2018 20-F 2020-12-14
Q3 2018 $3.97B $1B +$22.9M +2.33% Jul 1, 2018 Sep 30, 2018 20-F/A 2019-12-19
Q2 2018 $3.95B $1B +$35.5M +3.67% Apr 1, 2018 Jun 30, 2018 20-F/A 2019-12-19
Q1 2018 $3.92B $992M +$26.3M +2.73% Jan 1, 2018 Mar 31, 2018 20-F/A 2019-12-19
Q4 2017 $3.89B $978M +$23M +2.41% Oct 1, 2017 Dec 31, 2017 20-F/A 2019-12-19
Q3 2017 $3.87B $980M +$39.1M +4.15% Jul 1, 2017 Sep 30, 2017 20-F 2018-12-10
Q2 2017 $3.83B $967M +$36.6M +3.93% Apr 1, 2017 Jun 30, 2017 20-F 2018-12-10
Q1 2017 $3.79B $966M +$40.1M +4.33% Jan 1, 2017 Mar 31, 2017 20-F 2018-12-10
Q4 2016 $3.75B $955M +$33.2M +3.61% Oct 1, 2016 Dec 31, 2016 20-F 2018-12-10
Q3 2016 $3.72B $941M +$13.9M +1.5% Jul 1, 2016 Sep 30, 2016 20-F 2017-12-11
Q2 2016 $3.7B $930M +$22.2M +2.45% Apr 1, 2016 Jun 30, 2016 20-F 2017-12-11
Q1 2016 $3.68B $926M +$23.4M +2.59% Jan 1, 2016 Mar 31, 2016 20-F 2017-12-11
Q4 2015 $3.66B $922M +$15.2M +1.68% Oct 1, 2015 Dec 31, 2015 20-F 2017-12-11
Q3 2015 $3.64B $927M +$26.5M +2.95% Jul 1, 2015 Sep 30, 2015 20-F 2016-12-12
Q2 2015 $3.62B $908M +$5.42M +0.6% Apr 1, 2015 Jun 30, 2015 20-F 2016-12-12
Q1 2015 $3.61B $903M +$5.72M +0.64% Jan 1, 2015 Mar 31, 2015 20-F 2016-12-12
Q4 2014 $3.61B $906M +$42.2M +4.89% Oct 1, 2014 Dec 31, 2014 20-F 2016-12-12
Q3 2014 $3.56B $900M Jul 1, 2014 Sep 30, 2014 20-F 2015-12-10
Q2 2014 $902M Apr 1, 2014 Jun 30, 2014 20-F 2015-12-10
Q1 2014 $897M Jan 1, 2014 Mar 31, 2014 20-F 2015-12-10
Q4 2013 $864M Oct 1, 2013 Dec 31, 2013 20-F 2015-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.